Literature DB >> 28474051

Should tobacco and alcohol companies be allowed to influence Australia's National Drug Strategy?

Becky Freeman1, Ross MacKenzie2, Mike Daube3.   

Abstract

Formation of Australia's National Drug Strategy (NDS) included an extensive consultation process that was open not only to community and public health stakeholders, but also to representatives of the tobacco and alcohol industries. Australia is bound by the World Health Organization Framework Convention on Tobacco Control, which requires governments to protect tobacco control measures from interference by the tobacco industry. NDS consultation submissions made by these conflicted industries are not publicly available for scrutiny. The NDS goals are at odds with the commercial agenda of industries that support regulatory stagnation, oppose and undermine effective action, ignore and distort evidence, and prioritise profits over health.

Entities:  

Mesh:

Year:  2017        PMID: 28474051      PMCID: PMC5687808          DOI: 10.17061/phrp2721714

Source DB:  PubMed          Journal:  Public Health Res Pract        ISSN: 2204-2091


  3 in total

1.  Public health and the anticorporate movement: rationale and recommendations.

Authors:  William H Wiist
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

Review 2.  Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries.

Authors:  Rob Moodie; David Stuckler; Carlos Monteiro; Nick Sheron; Bruce Neal; Thaksaphon Thamarangsi; Paul Lincoln; Sally Casswell
Journal:  Lancet       Date:  2013-02-12       Impact factor: 79.321

3.  Exposing and addressing tobacco industry conduct in low-income and middle-income countries.

Authors:  Anna B Gilmore; Gary Fooks; Jeffrey Drope; Stella Aguinaga Bialous; Rachel Rose Jackson
Journal:  Lancet       Date:  2015-03-14       Impact factor: 79.321

  3 in total
  1 in total

1.  An evaluation of the evidence submitted to Australian alcohol advertising policy consultations.

Authors:  Julia Stafford; Tanya Chikritzhs; Hannah Pierce; Simone Pettigrew
Journal:  PLoS One       Date:  2021-12-10       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.